|
Quotes & Info
|
| CRXX > SEC Filings for CRXX > Form 8-K on 27-May-2009 | All Recent SEC Filings |
27-May-2009
Other Events, Financial Statements and Exhibits
On May 27, 2009, CombinatoRx, Incorporated ("CombinatoRx") issued a press release announcing the results from a Phase 2 clinical trial of CRx-401 in subjects with type 2 diabetes. The full text of CombinatoRx's press release regarding the announcement is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
(d) Exhibits
Exhibit No. Description
99.1 Press release of CombinatoRx, Incorporated dated May 27, 2009.
|
|